Cytek Biosciences Inc (CTKB) stock news · rev $201.5M
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
This CTKB news page leads with what Cytek Biosciences Inc filed — not a scraped headline mill.
No cached 8-K sentence for CTKB yet. We will not pad this page with generic market recap.
Latest reported CTKB revenue for 2025-12-31 was $201.5M. Net income was -$66.5M. Revenue was up 0.5% from 2024-12-31 to 2025-12-31. CTKB currently screens at market cap $421.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CTKB stock page; for the tape open the quote page.
CTKB stock news FAQ
What are CTKB's latest revenue and net income?
Latest cached Cytek Biosciences Inc (CTKB) revenue for Dec 31, 2025 was $201.5M. Net income was -$66.5M. Statements: https://lician.com/financials/ctkb
How did CTKB revenue change from the prior cached period?
Cached Cytek Biosciences Inc (CTKB) revenue was up 0.5% from $200.5M (Dec 31, 2024) to $201.5M (Dec 31, 2025). Statements: https://lician.com/financials/ctkb
What is CTKB's market cap?
Cytek Biosciences Inc (CTKB) market cap is $421.8M on the latest cached fundamentals snapshot.
What kind of company is CTKB?
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Where is CTKB stock news listed?
Cached stock news for Cytek Biosciences Inc (CTKB) is listed at https://lician.com/news/ctkb. Filings: https://lician.com/sec/ctkb
Not investment advice.